ペニシリン結合タンパク質からβ-ラクタマゼの進化の構造的側面
Samy O Meroueh1, George Minasov, Wenlin Lee
1Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, USA.
Journal of the American Chemical Society
|August 9, 2003
まとめ
バクテリアの耐性酵素であるβ-ラクタマゼは,ペプチドグリカンとの相互作用を防ぐために,ペニシリン結合タンパク質とは異なり,異なる活性部位を進化させた. 構造分析とシミュレーションにより,ペプチドーグリカン結合を廃止し,抗生物質耐性を可能にする修正が確認されています.
科学分野:
- バイオケミストリー バイオケミストリー
- 構造生物学 構造生物学とは
- 微生物学 微生物学とは
背景:
- ペニシリン結合タンパク質 (PBP) とβ-乳糖酵素は,進化の起源を共有しています.
- PBPはペプチドグリカンを使用して細菌の細胞壁を合成します.
- ベータ・ラクタマゼは,ベータ・ラクタム系抗生物質に対する耐性を付与する.
研究 の 目的:
- ベータ・ラクタマゼが抗生物質耐性酵素として機能することを可能にする構造変化を調査する.
- ベータ・ラクトマゼが,PBPの基質であるペプチドグリカンとの相互作用を避けるために進化したという仮説を検証する.
主な方法:
- セファロスポリンアナログ (化合物6) の合成
- X線結晶撮影により,セファロスポリン-AmpCベータ・ラクタマゼ複合体の構造を決定する.
- 複合体の分子動力学シミュレーション.
主要な成果:
- X線構造は,β-ラクタマース活性部位にペプチドグリカン相互作用表面がないことを明らかにした.
- ベータ・ラクタマースの活性部位にペプチドを挿入することで,ペプチドグリカン鎖との相互作用を防ぐ.
- 分子ダイナミクスシミュレーションでは,結合されたリガンドが安定していないことが示され,特定の結合の欠如を示しています.
結論:
- ベータ-ラクタマースの構造的変化により,ペプチドグリカンとの相互作用が防止されます.
- これらの変化は,抗生物質耐性における酵素の触媒能力にとって極めて重要です.
- この研究は,ベータ・ラクタマゼとPBPの進化的分岐を明らかにした.
関連する概念動画
01:49Conserved Binding Sites
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...